Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
Open Access
- 23 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Psychiatry
- Vol. 7 (1), 14
- https://doi.org/10.1186/1471-244x-7-14
Abstract
Not only the prevalence, but also the progress of metabolic abnormalities in schizophrenic patients is of importance for treatment planning and policy making. However, there have been very few prospective studies of metabolic disturbance in schizophrenic patients. This study aimed to assess the progress of metabolic abnormalities in Thai individuals with schizophrenia by estimating their one-year incidence rate of metabolic syndrome (MetS). We screened all schizophrenic patients who visited our psychiatric clinic. After the exclusion of participants with MetS at baseline, each subject was reassessed at 6 and 12 months to determine the occurrence of MetS. The definition of MetS, as proposed by the International Diabetes Federation (IDF), was applied. Fifty-seven participants (24 males and 33 females) had a mean of age and duration of antipsychotic treatment of 37.5 years old and 8.4 years, respectively. At baseline, 13 subjects met the MetS definition. Of 44 subjects who had no MetS at baseline, 35 could be followed up. Seven of these 35 subjects (20.0%) had developed MetS at the 6- or 12-month visit, after already having 2 MetS components at baseline. The demographic data and characteristics of those developing and not developing MetS were not different in any respect. Thai schizophrenic patients are likely to develop MetS. Their metabolic abnormalities may progress rapidly and fulfill the MetS definition within a year of follow-up. These findings support the importance of assessing and monitoring metabolic syndrome in schizophrenic patients.This publication has 19 references indexed in Scilit:
- Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the United Kingdom's General Practice Research DatabaseArchives of General Psychiatry, 2007
- New and Emerging Strategies for Reducing Cardiometabolic Risk FactorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular TrialsJournal of Cardiovascular Pharmacology, 2006
- A 4-Fold Risk of Metabolic Syndrome in Patients With SchizophreniaBritish Journal of Psychology, 2005
- Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic SyndromeThe Canadian Journal of Psychiatry, 2004
- Physical Health Monitoring of Patients With SchizophreniaAmerican Journal of Psychiatry, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cardiovascular Morbidity and Mortality Associated With the Metabolic SyndromeDiabetes Care, 2001